Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Young Insider Profile
4 Followers
David Young, Chief Scientific Officer at Questcor, holds 140.86K shares in Processa Pharmaceuticals (Ticker: PCSA), holds 117.74K shares in Questcor (Ticker: QCOR).
Profitable Transactions
0 out of 6 Profitable Transactions
Average Return
-62.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Pres. Research & Development, Director
Roles that David Young holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Young
David Young's Trading History
Questcor
Jun 26, 2014
―
Uninformative Sell
551.76K
―
Processa Pharmaceuticals
Apr 12, 2024
Pres. Research & Development, Director
Uninformative Buy
3.23K
$229.60K
List of latest transactions for each holding click on a transaction to see David Young's performance on stock
You May Also Like
David Young insider profile FAQ
What is the percentage of profitable transactions made by David Young?
The percentage of profitable transactions made by David Young is 0%.
What is the average return per transaction made by David Young?
The average return per transaction made by David Young is -62.10%.
What stocks does David Young hold?
David Young holds: QCOR, PCSA stocks.
What was David Young’s latest transaction?
David Young latest transaction was an Uninformative Buy of $3.23K.
What was David Young's most profitable transaction?
David Young’s most profitable transaction was an Informative Buy of PCSA stock on February 7, 2024. The return on the trade was -26.90%.
What is David Young's role in Questcor?
David Young's role in Questcor is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.